Citations 1
Post‐Marketing Safety of Bimekizumab in Psoriasis Patients: Pharmacovigilance Data From FDA Adverse Event Reporting System
Tran, Tung S, Le, Duc V. , Jacobs, Jena C., Nguyen, Trang M , Wetter, David A., Nguyen, Giang Huong , Tran, Tung S. , Le, Duc V. , Tran, Tung S , Le, Duc V. , Nguyen, Giang H , Nguyen, Trang M , Le, Duc V., Jacobs, Jena C., Wetter, David A.
International Journal of Dermatology | September 24, 2025 | Volume: 65 | Issue: 4 | Pages: 825-827
